Global Virtual Clinical Trials Market By Therapeutic Area (Cardiovascular Disorders, Metabolic Disorders, Infectious Diseases, Neurological Disorders, Respiratory Disorders, Oncological Disorders, and Others), By Clinical Trial Phase (Phase I, Phase II, Phase III, and Phase IV), By Company Size (SMEs and Large), By End-users (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Medical Device Industries, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
Report Overview The Global Virtual Clinical Trials Market size is expected to be worth around US$ 15.6 billion by 2033 from US$ 8.9 billion in 2023, growing at a CAGR of 5.8% during ...
